LifeScience Emerging Biotech

SineuGene Secures Dual U.S. and China IND Clearances for First-in-Class ALS Gene Therapy SNUG01

SineuGene Therapeutics Co., Ltd. ("SineuGene"), clinical-stage biotechnology company that mainly focuses on gene therapies for neurological disorders, anno...

 August 18, 2025 | News

Daewoong Korea’s Semaglutide Patch Achieves 80 Percent Bioavailability to Transform Obesity Care

More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and...

 August 14, 2025 | News

Shilpa Medicare Becomes World’s First to Gain Approval for NorUDCA, Pioneering Treatment for Over a Billion NAFLD Patients

  NAFLD affects 1 in 4 people globally (1.2 billion), with 188 million patients in India—most undiagnosed until irreversible damage...

 August 14, 2025 | News

Minghui Pharmaceutical Secures $131M Pre-IPO Funding to Accelerate Global Pipeline

Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company, today announced the closing of a USD 131 million Pre-IPO fin...

 August 08, 2025 | News

Precision Therapies Set to Unlock USD 1.6 Trillion in Economic Impact Across Asia-Pacific

As Asia-Pacific bears nearly half of the global cancer burden, precision medicine is emerging not only as a clinical breakthrough but also as a powerful ec...

 August 04, 2025 | Interview

Everest Medicines Invests US$30.9 Million in I-Mab to Advance Next-Gen Immuno-Oncology Therapies

- Everest will invest US$30.9 million (equivalent to approximately HK$242.6 million) in cash in I-Mab. Inclusive of I-MAB shares alread...

 August 04, 2025 | News

Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Inhaled Microbiome Therapeutics

Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingh...

 August 04, 2025 | News

XellSmart Achieves World-First Patient Dosing in Pioneering iPSC-Derived Cell Therapy Trial for Spinal Cord Injury

XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. achieved a significant milestone in its "world's first" China NMPA & US FDA-approved regis...

 July 30, 2025 | News

Bristol Myers Squibb and Bain Capital Launch New Biotech Company with $300M to Advance Autoimmune Therapies

Five immunology assets in-licensed from BMS with potential to address unmet needs for patients with autoimmune diseases, including late-stage asset for...

 July 29, 2025 | News

Biocytogen Expands Preclinical Capabilities Across Asia and the U.S. with Over 1,000 Humanized Mouse Models

Biocytogen (HKEX: 02315), an international biotechnology company that drives new drug development with innovative technologies,  announced that its pr...

 July 29, 2025 | News

Shanton Pharma’s SAP-001 Receives FDA Fast Track Designation for Refractory Gout Treatment

Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout,  announced that FDA has designated its Investigational New Dru...

 July 28, 2025 | News

GNT Pharma Receives South Korea’s Green Light to Launch Global Phase 3 Trials for Breakthrough Stroke Drug Nelonemdaz

GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, announced its IND Application to commence Glo...

 July 25, 2025 | News

New England Biolabs Launches Low-Bias Small RNA Library Prep Kit to Advance RNA Sequencing Accuracy

New England Biolabs (NEB®) nnounced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimize biased representation of s...

 July 23, 2025 | News

Illimis Therapeutics Raises Series B to Advance GAIA Platform for Alzheimer’s and Immune Disorders

The Series B round saw strong participation from both existing and new investors, demonstrating high industry confidence in Illimis Therapeutics' visi...

 July 15, 2025 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close